Extract notice to the Minister


Common name / Subject : ibrutinib (LLC)
Name of the manufacturer : Janss. Inc
Form : Caps.
Dosage : 140 mg

Indication : Leucémie lymphoïde chronique

INESSS' Recommendation

Minister's decisions
Inscrire aux listes des médicaments

Evaluation published on August 18, 2017

Download Advice to minister about Imbruvica

Extrait de l'Avis au ministre sur Imbruvica (LLC) 22 KiO

Subscribe to our newsletter now